Maximum quantity allowed is 999
请选择数量
CAS RN: 66357-35-5 | 產品號碼: R0261
| 產品號碼 | R0261 |
純度/分析方法 
|
>98.0%(T)(HPLC) |
| 分子式 / 分子量 | C__1__3H__2__2N__4O__3S = 314.40 |
| 外觀與形狀（20°C） | Solid |
| 儲存條件
|
Refrigerated (0-10°C) |
| 儲存在惰性氣體下 | Store under inert gas |
| 應避免的情況 | Air Sensitive,Heat Sensitive |
| 包裝和容器
|
1G-Glass Bottle with Plastic Insert （閲覽圖片） |
| CAS RN | 66357-35-5 |
| Reaxys-RN | 4845772 |
| MDL編號 | MFCD00081180 |
產品規格
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| Melting point | 69.0 to 73.0 °C |
| NMR | confirm to structure |
性質
| 熔點 | 72 °C |
| 水溶性 | Soluble |
GHS
相關法規
| RTECS # | KM6556500 |
運輸資料
| HS編碼* | 2932.19-000 |
Application
Ranitidine: A Histamine H2-Receptor Antagonist
Ranitidine and its hydrochloride [R0073] are histamine H2-receptor antagonists. They have been reported as a potent inhibitors of gastric acid secretion effective in the treatment and prophylaxis of gastrointestinal lesions aggravated by gastric acid secretion. (The product is for research purpose only.)
References
- Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases
- Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases
- Ranitidine (a review on synthesis, physical properties, stability, methods of analysis and pharmacokinetics of ranitidine)
產品文件 （部分產品的分析圖譜無法提供，敬請諒解。）
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助，請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注：該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉，您搜索的分析圖譜無法提供。